期刊
ANNALS OF THE AMERICAN THORACIC SOCIETY
卷 12, 期 12, 页码 1764-1770出版社
AMER THORACIC SOC
DOI: 10.1513/AnnalsATS.201507-472OC
关键词
bronchiectasis; etiology; severity of illness index
资金
- European Bronchiectasis Network (EMBARC), a European Respiratory Society Clinical Research Collaboration
- Medical Research Council (MRC)
- Wellcome Trust
- European Respiratory Society/European Lung Foundation
- Health Research Board, Ireland
- National Institute for Health Research Biomedical Research Centre
- MRC
- NHLBI [K23HL096054]
- MRC [MR/L011263/1] Funding Source: UKRI
- Medical Research Council [MR/L011263/1] Funding Source: researchfish
Rationale: Testing for underlying etiology is a key part of bronchiectasis management, but it is unclear whether the same extent of testing is required across the spectrum of disease severity. Objectives: The aim of the present study was to identify the etiology of bronchiectasis across European cohorts and according to different levels of disease severity. Methods: We conducted an analysis of seven databases of adult outpatients with bronchiectasis prospectively enrolled at the bronchiectasis clinics of university teaching hospitals in Monza, Italy; Dundee and Newcastle, United Kingdom; Leuven, Belgium; Barcelona, Spain; Athens, Greece; and Galway, Ireland. All the patients at every site underwent the same comprehensive diagnostic workup as suggested by the British Thoracic Society. Measurements and Main Results: Among the 1,258 patients enrolled, an etiology of bronchiectasis was determined in 60%, including postinfective (20%), chronic obstructive pulmonary disease related (15%), connective tissue disease related (10%), immunodeficiency related (5.8%), and asthma related (3.3%). An etiology leading to a change in patient's management was identified in 13% of the cases. No significant differences in the etiology of bronchiectasis were present across different levels of disease severity, with the exception of a higher prevalence of chronic obstructive pulmonary disease-related bronchiectasis (P < 0.001) and a lower prevalence of idiopathic bronchiectasis (P = 0.029) in patients with severe disease. Conclusions: Physicians should not be guided by disease severity in suspecting specific etiologies in patients with bronchiectasis, although idiopathic bronchiectasis appears to be less common in patients with the most severe disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据